Consumo de Imipenem/Cilastatina en pacientes hospitalizados en el Hospital Florencia de Mora nivel I, Trujillo, Enero – Diciembre 2019
No Thumbnail Available
Date
2021
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
El presente estudio tiene como objetivo determinar el consumo de Imipenem 500 mg/Cilastatina 500mg en pacientes hospitalizados del Hospital Florencia de Mora nivel I, Trujillo, Enero – Diciembre 2019 Nivel I– Essalud Trujillo de enero-diciembre del 2019. Se recolectaron los datos del consumo de Imipenem 500 mg/Cilastatina 500mg de los servicios Medicina, Cirugía, Ginecología y Obstetricia. La población en estudio comprendió todos los pacientes hospitalizados de ambos sexos y todas las edades que recibieron terapia con Imipenem 500 mg/Cilastatina 500mg en los servicios durante el año 2019 los datos fueron obtenidos del Sistema de Gestión Hospitalaria del Hospital I de Florencia de Mora – Es salud Trujillo El perfil del consumo de Imipenem/Cilastatina 500 mg expresado en meses nos indicó en el mes de diciembre hubo un mayor consumo con un DDD/100 camas/día de 14.42% y el de menor consumo fue en junio con un DDD/100 camas/día de 6.32%. . Se concluye que debería de implementarse el PROA (Programas de optimización de uso de antimicrobianos) lo cual es esencial en este hospital para la optimización de antibióticos de reserva.
ABSTRACT The objective of the present study is to determine the consumption of Imipenem 500 mg / Cilastatina 500mg in hospitalized patients at Hospital Level I - Es Salud Trujillo from January-December 2019. Data from the Medicine, Surgery, Gynecology services were collected and Obstetrics, the study population comprised all hospitalized patients of both sexes and all ages who received therapy with Imipenem 500 mg / Cilastatin 500mg in the services during the year 2019, the data were obtained from the Hospital Management System of Hospital I of Florencia de blackberry - It's health Trujillo The profile of the consumption of Imipenem / Cilastatin 500 mg expressed in months indicated to us in the month of December there was a higher consumption with a DDD / 100 beds / day of 14.42% and the one with the lowest consumption was in June with a DDD / 100 beds / day of 6.32%. . It is concluded that the presence of the Pharmaceutical Chemist professional and the PROA (Antimicrobial use optimization programs) is essential in this hospital for the optimization of reserve antibiotics.
ABSTRACT The objective of the present study is to determine the consumption of Imipenem 500 mg / Cilastatina 500mg in hospitalized patients at Hospital Level I - Es Salud Trujillo from January-December 2019. Data from the Medicine, Surgery, Gynecology services were collected and Obstetrics, the study population comprised all hospitalized patients of both sexes and all ages who received therapy with Imipenem 500 mg / Cilastatin 500mg in the services during the year 2019, the data were obtained from the Hospital Management System of Hospital I of Florencia de blackberry - It's health Trujillo The profile of the consumption of Imipenem / Cilastatin 500 mg expressed in months indicated to us in the month of December there was a higher consumption with a DDD / 100 beds / day of 14.42% and the one with the lowest consumption was in June with a DDD / 100 beds / day of 6.32%. . It is concluded that the presence of the Pharmaceutical Chemist professional and the PROA (Antimicrobial use optimization programs) is essential in this hospital for the optimization of reserve antibiotics.
Description
Keywords
Antibióticos